|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash | ||||
| Deferred offering costs | ||||
| Prepaid expenses | ||||
| Marketable securities held in trust | ||||
| Total current assets | ||||
| Marketable Securities held in trust account | ||||
| Total assets | ||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Related Party Payable | ||||
| Deferred underwriting fee payable | ||||
| Total current liabilities | ||||
| Total non-current liabilities | ||||
| Total liabilities | ||||
| Mezzanine equity | ||||
| Class A Common stock subject to possible redemption, 10,626,000 shares outstanding common stock at redemption value of $10.15 per share | ||||
| Class A Common stock subject to possible redemption; 10,626,000 shares outstanding common stock at redemption value of $10.15 per share | ||||
| Stockholders' deficit: | ||||
| Class A Common stock, $0.0001 par value, 100,000,000 shares authorized; 675,670 shares outstanding common stock (excluding 10,626,000 shares subject to redemption) | ||||
| Common Class A | ||||
| Common Class B | ||||
| Total class A Common stock, $0.0001 par value, 100,000,000 shares authorized; 675,670 shares outstanding common stock (excluding 10,626,000 shares subject to redemption) | ||||
| Class B Common stock; $0.0001 par value, 20,000,000 shares authorized, 2,656,500 shares issued outstanding | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total stockholders’ deficit | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...
